Complete Filing Data
X Financial reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $6.95 billion for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean X Financial did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | $1.54B | $1.19B | $812.0M | $825.4M | -$1.31B | $774.3M | $883.1M | $340.3M | -$119.6M |
| Revenue From Contract With Customer Excluding Assessed Tax | $5.87B | $4.81B | $3.56B | $3.63B | $2.19B | $3.09B | $3.54B | $1.79B | $230.3M |
| Other Nonoperating Income Expense | $1.9M | $24.4M | $40.7M | $32.5M | $12.7M | $26.1M | -$5.9M | $89.7K | -$9.3K |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $11.6M | $5.4M | $57.1M | -$14.7M | -$46.0M | $14.6M | $19.0M | -$24.5M | $27.9M |
| Operating Income Loss | $256.7M | $1.46B | $1.21B | $1.31B | -$1.43B | $812.6M | $1.28B | $501.7M | -$136.8M |
| Interest Income Expense Nonoperating Net | -$559.7K | -$20.4M | $3.8M | $19.7M | $21.7M | $19.4M | $4.2M | $3.6M | $256.8K |
| Income Taxes Paid Net | $289.1M | $102.3M | $37.4M | $31.0M | $107.8M | $43.1M | $302.2M | $147.8K | $17.9K |
| Income Tax Expense Benefit | $55.6M | $261.1M | $396.1M | $368.7M | -$299.9M | -$93.1M | -$209.9M | $138.2M | -$27.0M |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $259.5M | $1.47B | $1.22B | $1.19B | -$1.60B | $663.9M | $1.08B | $478.6M | -$147.2M |
| General And Administrative Expense | $24.1M | $153.9M | $143.2M | $187.9M | $179.2M | $227.5M | $220.0M | $98.2M | $61.7M |
| Cost Of Revenue | $1.74B | $1.54B | $1.34B | $1.96B | $2.07B | $1.63B | $1.19B | $760.1M | $259.1M |
| Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest | $1.55B | $1.19B | $869.3M | $810.7M | -$1.35B | $789.1M | $902.1M | $315.0M | -$92.3M |
| Comprehensive Income Net Of Tax | $1.55B | $1.19B | $869.3M | $810.7M | -$1.35B | $788.9M | $902.2M | $315.8M | -$91.7M |
| Income Loss From Equity Method Investments | $10.2M | -$1.9M | -$42.3M | $3.3M | -$6.8M | $17.5M | $8.1M | -$832.4K | |
| Net Income Loss Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | -$478.00 | $41.1K | $199.9K | -$55.1K | -$780.4K | -$606.6K |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $0.00 | $0.00 | $0.00 | -$478.00 | $41.1K | $199.9K | -$55.1K | -$780.4K | -$606.6K |
| Selling And Marketing Expense | $12.5M | $15.4M | $20.8M | $35.6M | $103.2M | $205.7M | $76.6M | $38.2M | |
| Deferred Income Taxes And Tax Credits | -$3.7M | -$17.6M | $202.3M | $333.4M | -$142.6M | -$164.9M | -$3.2M | -$257.1M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.95B | $5.85B | $4.75B | $3.98B | $3.07B | $4.37B | $3.52B | $1.76B | $376.5M | $410.0M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $227.6M | $1.94B | $1.01B | $992.0M | $1.60B | $1.52B | $1.28B | $684.0M | $504.7M | $363.5M |
| Allowance For Doubtful Accounts Receivable And Contract Assets | $3.3M | $1.3M | $21.9M | $25.9M | $38.7M | $192.9M | $221.2M | $175.8M | $8.1M | |
| Provision For Accounts Receivable And Contract Assets | $35.7M | $12.2M | $21.8M | $77.2M | $121.5M | $241.2M | $397.0M | $167.7M | $8.1M | |
| Gain Loss On Sale Of Property Plant Equipment | $56.3K | -$148.2K | $2.7K | $180.5K | -$59.2K | $2.4K | $66.00 | $103.00 | $1.4K | |
| Changes In Fair Value Of Loans And Payable To Investors | $0.00 | $531.2K | $6.2M | $7.3M | $57.4M | -$64.2M | -$12.4M | $9.8M | -$4.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$282.9M | $937.5M | $14.9M | -$606.5M | $78.2M | $242.6M | $593.7M | $179.3M | $141.2M | |
| Cash And Cash Equivalents At Carrying Value | $984.6M | $1.20B | $602.3M | $584.8M | $746.4M | $1.01B | $1.07B | $671.4M | $504.2M | |
| Provision For Contingent Guarantee Liabilities | $33.1M | $67.5M | -$14.0M | -$24.3K | $880.9K | $7.7M | $216.4M | $182.6M | ||
| Restricted Cash Current | $676.8M | $749.1M | $404.7M | $407.3M | $852.1M | $514.3M | $208.3M | $12.6M | $483.9K | |
| Repayments Of Short Term Debt | $50.7M | $307.7M | $166.5M | $450.5M | $161.0M | $401.0M | ||||
| Retained Earnings Accumulated Deficit | $571.9M | $2.69B | $1.62B | $810.9M | -$14.6M | $1.31B | $640.1M | -$243.0M | ||
| Property Plant And Equipment Net | $2.2M | $8.6M | $5.9M | $6.2M | $11.1M | $20.1M | $23.2M | $21.0M | ||
| Prepaid Expense And Other Assets Current | $4.7M | $48.8M | $71.1M | $213.1M | $403.8M | $707.4M | $115.2M | $82.1M | ||
| Other Assets Noncurrent | $45.0M | $55.3M | $67.2M | $31.3M | $51.5M | $68.8M | $6.8M | $3.8M | ||
| Long Term Investments | $498.0M | $493.4M | $496.0M | $560.0M | $295.6M | $292.1M | $287.2M | $54.2M | ||
| Liabilities And Stockholders Equity | $11.82B | $11.65B | $8.84B | $7.34B | $7.50B | $8.28B | $4.64B | $3.89B | ||
| Liabilities | $4.87B | $5.80B | $4.08B | $3.37B | $4.42B | $3.91B | $1.12B | $2.12B | ||
| Intangible Assets Net Excluding Goodwill | $36.6M | $36.8M | $36.5M | $36.8M | $37.4M | $35.1M | $28.4M | $1.6M | ||
| Employee Related Liabilities Current And Noncurrent | $13.0M | $86.8M | $63.7M | $44.6M | $34.8M | $63.6M | $93.5M | $77.8M | ||
| Common Stock Value | $206.8K | $206.8K | $206.8K | $206.8K | $202.9K | $201.2K | $189.6K | $173.4K | ||
| Assets | $1.62B | $11.65B | $8.84B | $7.34B | $7.50B | $8.28B | $4.64B | $3.89B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $81.1M | $69.5M | $63.6M | $6.3M | $21.1M | $67.1M | $52.5M | $33.4M | ||
| Accrued Liabilities And Other Liabilities | $929.5M | $575.7M | $476.0M | $269.0M | $323.7M | $274.4M | $178.7M | $137.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $5.5M | $42.6M | $53.5M | $88.4M | $80.1M | $157.1M | $171.8M | $74.0M | $37.9M |
| Proceeds From Sale Of Property Plant And Equipment | $14.8K | $18.1K | $5.4K | $236.8K | $79.3K | $115.4K | $5.3K | $3.0K | $8.4K |
| Payments To Acquire Property Plant And Equipment | $14.2M | $8.5M | $6.1M | $2.6M | $5.4M | $15.1M | $38.6M | $20.6M | $3.4M |
| Net Cash Provided By Used In Operating Activities | $1.52B | $1.39B | $626.8M | $449.2M | -$679.2M | $600.6M | $5.4M | -$615.3M | $82.6M |
| Net Cash Provided By Used In Investing Activities | $16.7M | -$1.68B | -$1.22B | -$2.35B | -$3.70B | -$3.08B | $412.9M | -$10.8M | -$734.7M |
| Net Cash Provided By Used In Financing Activities | -$265.1M | $1.23B | $576.4M | $1.30B | $4.49B | $2.71B | $181.8M | $830.2M | $775.2M |
| Increase Decrease In Property And Other Taxes Payable | -$1.3M | $34.1M | $36.1M | $146.5M | $15.0M | -$76.0M | $28.2M | $89.8M | $12.0M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$14.3M | -$7.9M | -$121.8M | -$21.2M | -$123.9M | $197.1M | $6.4M | $11.9M | $56.0M |
| Increase Decrease In Other Noncurrent Assets | $1.1M | $121.1K | -$1.6M | -$162.7K | -$265.8K | -$299.9K | $3.1M | $1.4M | $8.1M |
| Increase Decrease In Employee Related Liabilities | $1.1M | $23.1M | $19.1M | $9.8M | -$28.9M | -$29.8M | $15.7M | $31.0M | $42.0M |
| Increase Decrease In Accrued Income Taxes Payable | $19.7M | $176.4M | $152.9M | $41.2M | -$265.1M | $28.8M | -$89.1M | $395.2M | $6.1M |
| Increase Decrease In Accrued Expenses And Other Current Liabilities | $114.9M | $92.4M | $65.1M | -$33.7M | $102.8M | $64.4M | $38.0M | $29.2M | $100.4M |
| Increase Decrease In Accounts Receivable And Contract Assets | $405.7M | $509.9M | $436.3M | $411.4M | -$220.8M | -$367.0M | $665.3M | $1.14B | $95.6M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.9M | $2.3M | $29.3M | -$9.4M | -$28.4M | $10.6M | -$6.3M | -$24.7M | $18.2M |
| Depreciation Depletion And Amortization | $986.2K | $5.3M | $6.6M | $8.1M | $11.9M | $11.4M | $9.6M | $5.4M | $3.1M |
| Increase Decrease In Derivative Liabilities | $0.00 | -$82.9M | -$223.9M | $551.3M | $388.8M | -$608.1M | -$612.5M | $35.2M | |
| Increase Decrease In Guarantee Liabilities | -$116.0M | -$5.6M | $14.0M | -$9.8M | -$8.0M | -$3.4M | -$524.3M | $444.5M | $91.0M |
| Proceeds From Short Term Debt | $133.5M | $802.5M | $70.2M | $266.5M | $511.5M | $203.0M | $198.0M | ||
| Payments To Investors In Consolidated Trusts | $0.00 | $141.3M | $420.2M | $1.91B | $2.63B | $1.31B | $696.8M | $1.16B | $10.0M |
| Increase Decrease In Deposit Payable | -$1.1M | $0.00 | -$1.3M | -$460.0K | -$87.5M | -$25.1M | -$220.1K | -$57.2M | |
| Payments To Fund Short Term Loans To Related Parties | $0.00 | $70.0M | $826.0M | $2.24B | $4.02B | $4.94B | $67.9M | $217.0M | |
| Proceeds From Stock Options Exercised | $122.5K | $1.1M | $277.3K | $3.0M | $612.5K | $6.0M | |||
| Proceeds From Investors In Consolidated Trusts | $0.00 | $0.00 | $98.8M | $454.5M | $1.54B | $4.31B | $1.10B | $770.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $0.72 | $4.08 | $2.52 | $2.45 | $-4.07 | $2.42 | $2.91 | $1.22 | $-0.50 |
| Earnings Per Share Basic | $0.73 | $4.12 | $2.57 | $2.51 | $-4.07 | $2.47 | $3.08 | $1.30 | $-0.50 |
| Weighted Average Number Of Shares Outstanding Basic | 288.8M | 288.1M | 316.4M | 329.2M | 321.2M | 313.8M | 286.6M | 261.2M | 238.1M |
| Weighted Average Number Of Diluted Shares Outstanding | 293.4M | 290.8M | 322.4M | 336.9M | 321.2M | 319.7M | 304.0M | 279.7M | 238.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Guarantees Fair Value Disclosure | $187.6M | $61.9M | $0.00 | $0.00 | $9.8M | $17.5M | $20.9M | $545.2M | $100.7M | $9.7M |
| Foreign Currency Transaction Gain Loss Before Tax | -$9.5M | -$4.0M | -$20.0M | $5.1M | $15.4M | $616.4K | $9.7K | -$478.6K | -$18.2K | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.5M | $42.6M | $53.5M | $88.4M | $80.1M | $157.1M | $171.8M | $74.0M | $37.9M | |
| Unrealized Gain Loss On Derivatives | $1.0M | $25.0M | $137.7M | -$170.3M | -$163.7M | -$246.4M | -$201.0M | -$18.1M | ||
| Costs And Expenses | $4.00B | $3.35B | $2.35B | $2.32B | $3.62B | $2.28B | $2.27B | $1.29B | $367.1M | |
| Interest Paid Net | $3.3M | $23.2M | $2.0M | $6.7M | $11.4M | $3.5M | ||||
| Stock Issued During Period Value Stock Options Exercised | $122.5K | $1.1M | $277.3K | $3.0M | $612.5K | $6.0M | ||||
| Deposits | $12.0M | $19.7M | $19.7M | $21.0M | $21.5M | $108.9M | $134.0M | $134.3M | ||
| Additional Paid In Capital | $3.21B | $3.20B | $3.19B | $3.16B | $3.07B | $2.99B | $2.82B | $1.97B |
Most recent annual filing with the SEC: April 25, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.